ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea flag South Korea · Delayed Price · Currency is KRW
941.00
-33.00 (-3.39%)
At close: Apr 20, 2026

KOSDAQ:034940 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6,806-9,605-10,514560.69-8,044
Depreciation & Amortization
2,4322,3892,3872,3882,893
Loss (Gain) From Sale of Assets
-1,544-293.83-85.73--8.72
Asset Writedown & Restructuring Costs
1,129246.281,989107.11,938
Loss (Gain) From Sale of Investments
-450.842.95-171.99-235.85-1,605
Loss (Gain) on Equity Investments
-7.09-14.78-19.874.83-17.96
Provision & Write-off of Bad Debts
-90.71504.79202.2-230.01269.87
Other Operating Activities
3,9332,6664,3841,8643,899
Change in Accounts Receivable
450.31,5432,287-2,644400.47
Change in Inventory
700.84596.73-2,212-549.252,292
Change in Accounts Payable
-1,373-646.98507.621,30481.5
Change in Other Net Operating Assets
-2,553-1,856-228.1-4,012-3,580
Operating Cash Flow
-4,180-4,468-1,475-1,443-1,480
Capital Expenditures
-1,986-551.31-831.13-2,782-3,544
Sale of Property, Plant & Equipment
2,612481.47128.61-14.55
Sale (Purchase) of Intangibles
-36.41-229.11-111.52-140.19-319.99
Investment in Securities
3,151-1,1591,9441,4791,566
Other Investing Activities
189.62-343.71-398.94-110.22417.53
Investing Cash Flow
3,931-1,802731.38-1,553-1,866
Long-Term Debt Issued
30,1669,63015,3497,6589,344
Long-Term Debt Repaid
-28,910-3,406-17,012-5,863-4,621
Net Debt Issued (Repaid)
1,2566,224-1,6621,7954,723
Other Financing Activities
-734-32-27.2211.51101.29
Financing Cash Flow
521.636,192-1,6901,8074,825
Foreign Exchange Rate Adjustments
-45.09127.94-44.95-33.84106.45
Net Cash Flow
227.5950.04-2,478-1,2231,585
Free Cash Flow
-6,165-5,019-2,306-4,225-5,024
Free Cash Flow Margin
-10.39%-8.01%-3.66%-6.13%-8.73%
Free Cash Flow Per Share
-199.30-162.01-74.45-136.37-162.17
Cash Interest Paid
1,0711,026913.95564.55287.07
Cash Income Tax Paid
-3.2714.42-10.98-45.22-
Levered Free Cash Flow
-5,338-894.16-850.27-3,337-3,096
Unlevered Free Cash Flow
-4,594-197.11-238.19-2,914-2,861
Change in Working Capital
-2,775-363.43354.91-5,902-805.67
Source: S&P Global Market Intelligence. Standard template. Financial Sources.